| Literature DB >> 21106939 |
Abstract
Translational research on endogenous gaseous mediators--nitric oxide, carbon monoxide, and hydrogen sulfide--has exploded over the past decade. Drugs that modulate either the gaseous mediators themselves or their related intracellular signaling pathways are already in use in the clinics, and still more are being tested in preclinical models and clinical trials. Discussed here are the chemical and pharmacological properties that present challenges for the translation of these potentially toxic molecules.Entities:
Mesh:
Substances:
Year: 2010 PMID: 21106939 PMCID: PMC3038605 DOI: 10.1126/scitranslmed.3000721
Source DB: PubMed Journal: Sci Transl Med ISSN: 1946-6234 Impact factor: 17.956